Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury Source: Eur Respir J 2003; 22: 20-27 Year: 2003
Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017
Hsp90 binding inhibitors improve survival in a murine model of sepsis induced acute lung injury Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006
Effect of phosphodiesterase-4 inhibitor on the inflammation, oxidative damage and apoptosis in a saline lavage-induced model of acute lung injury Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Effects of a selective phosphodiesterase IV and V inhibitor in a murine model of chronic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004
Three different agents cause similar acute responses after induced lung injury Source: Eur Respir J 2006; 28: Suppl. 50, 636s Year: 2006
The therapeutic potential of a new phosphodiesterase inhibitor in acute respiratory distress syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 36s Year: 2002
A novel approach for optimal lung recruitment in acute lung injury Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005
The effect of mercaptoethylguanidine on acute lung injury associated with sepsis Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003
Gabexate mesilate attenuates ischemia-reperfusion injury of lung grafts via the inhibition of neutrophil activation Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Combined inhalation of iloprost and the dual selective phosphodiesterase (PDE) inhibitor tolafentrine in a model of acute pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 198s Year: 2001
The anti-inflammatory effects of helminth-derived peptides in a model of endotoxin-induced acute lung injury Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011
Rho-kinase inhibitor ameliorates bleomycin-induced chronic lung injury in neonatal rats Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
The effects of repeated recruitment maneuver on acute lung injury in animal models Source: Eur Respir J 2002; 20: Suppl. 38, 35s Year: 2002
Phosphodiesterase 4 and 5 inhibitor and steroid actions on pulmonary injury induced by microcystin-LR Source: Annual Congress 2008 - Respiratory structure and function Year: 2008
Glucocorticoid receptor expression in different rat models of acute lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004
Antithrombin plus alpha–1 protease inhibitor does not affect pulmonary inflammation and coagulation in a ‘double-hit’ lung injury model Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018
Cilomilast, a potent, selective inhibitor of phosphodiesterase 4, improves small airway function in patients with chronic obstructive pulmonary disease: results of a 6-month trial Source: Eur Respir J 2001; 18: Suppl. 33, 94s Year: 2001